Global Trust Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
Other funds holding FBT
BFG
Global Trust Asset Management's FBT Position: Q2 2026 in Review
Global Trust Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 50% in Q2 2026, selling an estimated $8.62K and leaving 40 shares worth $9.92K. The position accounts for ﹤0.01% of the portfolio, ranked #340.
Global Trust Asset Management first reported a position in FBT in Q1 2018 and has held it in 20 quarters since. The position peaked at $713K in Q2 2020. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.
- Global Trust Asset Management held 40 shares of First Trust NYSE Arca Biotechnology Index Fund worth $9.92K as of Q2 2026.
- Global Trust Asset Management sold 40 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $8.62K.
- First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #340 holding.
- Global Trust Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2018 and has held it in 20 quarters since.
- Global Trust Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $713K in Q2 2020.
- 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.
Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.